KoBioLabs, Inc specializes in microbiome therapeutics and has developed technology for the treatment of various diseases, with a focus on high biofarmaceuticals manufacturing. The company has completed global clinical trials and received FDA approval for their products. They also have partnerships and joint ventures for the development of health functional food and digital bio-healthcare platforms. KoBioLabs, Inc. operates in the microbiome industry.

Headquarters
628, 220 Dong, Research Institute Of Bio
Seoul; Seoul;

Contact Details: Purchase the Kobiolabs, Inc report to view the information.

Website: http://kobiolabs.com

Basic Information

Total Employees:

Purchase the Kobiolabs, Inc report to view the information.

Outstanding Shares:

Purchase the Kobiolabs, Inc report to view the information.

Registered Capital:

Purchase the Kobiolabs, Inc report to view the information.

Financial Auditors:

Purchase the Kobiolabs, Inc report to view the information.

Incorporation Date:

August 11, 2014

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Subsidiaries

Kobiolabs Australia Pty Ltd

Company Performance

Financial values in the chart are available after Kobiolabs, Inc report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

6.84%▲

Total Operating Revenue

5.79%▲

Operating Profit

-41.74%▼

EBITDA

-61.9%▼

Net Profit/Loss for the Period

-54.4%▼

Total Assets

-10.13%▼

Total Equity

-14.22%▼

Operating Profit Margin

-3%▼

Net Profit Margin

-3.07%▼

Return on Equity (ROE)

-4.8%▼

Debt / Equity

-572%▼

Quick Ratio

29.03%▲

Cash Ratio

-0.07%▼

Kobiolabs, Inc (South Korea)